Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of Fibrin Sealant With 4 IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS VH S/D 4) in Face-Lift Procedures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects planned for facial rhytidectomy~* Subjects who read, understand and sign the written informed consent~* Healthy female or male subjects as determined by the investigator using standard pre-operative assessments to include laboratory tests and ECG~* Subjects 18-75 years old, inclusively~* Subjects who are able and willing to comply with the protocol requirements~* Female subjects of childbearing potential with a negative urine or serum pregnancy test within 72 hours of surgery~Exclusion Criteria:~* Pregnant or lactating women~* Subjects who have undergone previous face-lift surgery~* Subjects undergoing abbreviated face-lift procedures such as deep plane procedures, minimal undermining procedures, thread lifts, and minimal access cranial suspension~* Subjects indicated for concurrent facial surgeries during the operation (e.g. forehead plasty, blepharoplasty, rhinoplasty, buccal fat removal, any filler injections including fat injections, lip augmentation, skin resurfacing procedures etc.)~* Subjects indicated for additional procedures during the same operation (e.g., liposuction, mastoplasty etc.)~* Subjects who had prior silicone injections to their face (Botox and/or Restylane are allowed)~* Subjects considered by the investigator to be smokers~* Subjects with ecchymosis and/or edema on the face on day 0, prior to surgery~* Subjects with known (documented) bleeding or coagulation disorders~* Subjects currently being treated with anti-coagulants~* Subjects treated with Aspirin in the last 7 days or use of other Non-steroidal anti-inflammatory drug (NSAIDs) within the last 7 days prior to surgery~* Subjects with vascular disorders, cardiovascular disease, and/or uncontrolled hypertension~* Subjects with diabetes mellitus~* Subjects with a history of Bell´s palsy~* Subjects with connective tissue disorders~* Subjects with documented history of pathologically or pharmacologically induced immune deficiency~* Subjects receiving systemic corticosteroid treatment for a chronic condition within 2 to 30 days prior to the surgery~* Subjects with a known sensitivity to fibrin sealants~* Subjects with a known psychiatric disorder (e.g., depression, obsessive compulsive disorder, anxiety, eating disorders, etc)~* Subjects who have participated in another clinical study within 30 days prior to this study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): One side of the face is treated with FS VH S/D 4; the other side of the face is treated using standard of care.

Based on this trial design, predict the completion outcome and termination type (if applicable).